CONCERTO ICD/CONSULTA/CONCERTO II/MAXIMO II CRT-D/INSYNC II/III MARQUIS/MARQUIS DR/INSYNC MARQUIS/MAXIMO/SENTRY
FDA premarket approval P010031/S254 · decided 2011-06-08
Approval details
- PMA number
- P010031
- Supplement
- S254
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- CONCERTO ICD/CONSULTA/CONCERTO II/MAXIMO II CRT-D/INSYNC II/III MARQUIS/MARQUIS DR/INSYNC MARQUIS/MAXIMO/SENTRY
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2011-05-09
- Decision date
- 2011-06-08
- Days to decision
- 30 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- CHANGES TO THE NELIPAK SEALER MANUFACTURING PROCESS; INCLUDING ADDITION OF NEW EQUIPMENT, A CHANGE TO THE PROCESS RECIPE SPECIFICATION, AND THE IMPLEMENTATION OF A MONITORING TEST.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.